Lunate Capital Ltd

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 17, 2025), Lunate Capital Ltd reported 5 stock positions worth $178.0 million. Its top holding was Revolution Medicines (RVMD) at 45.4% of the portfolio, followed by Sailpoint (SAIL, 38.5%) and Lineage (LINE, 14.7%). Compared with Q1 2025, it opened 1 new position. The biggest buy was a new position in Samsara Class A (IOT).

Most Recent 13F
Q2 2026
Location
AL MARYAH ISLAND, ABU DHABI, C0
CIK
0002056786
Portfolio Value
$178.0M (Q2 2025)
SEC Filing
0001011438-25-000357 ↗ filed Jul 17, 2025

Holdings Value

0$100.0M$200.0M$300.0M Q1 2025: $171.2M Q1 2025 Q2 2025: $178.0M $178.0M Q2 2025 Q3 2025: $220.6M Q3 2025 Q4 2025: $263.8M Q4 2025 Q1 2026: $119.6M Q1 2026 Q2 2026: $196.0M Q2 2026

Holdings 5 stocks · $178.0M
RVMD Revolution Medicines Inc. 45.40% 2,196,200 $80.8M No change
SAIL Sailpoint Inc. 38.54% 3,000,000 $68.6M No change
LINE Lineage Inc. 14.67% 600,000 $26.1M No change
NMRA Neumora Therapeutics Inc. 0.88% 2,124,143 $1.6M No change
IOT Samsara Inc. Class A 0.51% 22,751 $905K New
Other holdings (1): bonds, preferreds, convertibles and warrants · $118K (not counted above)
SecurityClassShares / PrincipalValueChange
RVMDW Revolution Medicines Inc.-28 *W EXP 12/17/202 450,000$118KNew

Total filed on the 13F, all lines: $178.1M.

Portfolio Sells Q1 2025 → Q2 2025
None this quarter.

Portfolio Buys Q1 2025 → Q2 2025
IOT Samsara Inc. Class A New 0.51% +0.51

Notes & Other Activity Q1 2025 → Q2 2025
RVMDW Revolution Medicines Inc.-28 *W EXP 12/17/202 New 450,000 $118K

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 10$196.0MSAIL, BIRK, LINE, BXSL, GSBD
Q1 2026 5$119.6MRVMD, SAIL, LINE, NMRA, NAVN
Q4 2025 5$263.8MRVMD, SAIL, LINE, NMRA, NAVN
Q3 2025Amended 5$220.6MRVMD, SAIL, FIGR, LINE, NMRA
Q2 2025 5$178.0MRVMD, SAIL, LINE, NMRA, IOT
Q1 2025 4$171.2MRVMD, SAIL, LINE, NMRA